KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Supernus Pharmaceuticals (SUPN) over the last 15 years, with Q3 2025 value amounting to $468.6 million.

  • Supernus Pharmaceuticals' Change in Acquisitions & Divestments rose 21634.18% to $468.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $868.1 million, marking a year-over-year increase of 11622.71%. This contributed to the annual value of $498.9 million for FY2024, which is 3450.25% up from last year.
  • As of Q3 2025, Supernus Pharmaceuticals' Change in Acquisitions & Divestments stood at $468.6 million, which was up 21634.18% from $110.4 million recorded in Q2 2025.
  • In the past 5 years, Supernus Pharmaceuticals' Change in Acquisitions & Divestments ranged from a high of $468.6 million in Q3 2025 and a low of $17.6 million during Q4 2022
  • Moreover, its 5-year median value for Change in Acquisitions & Divestments was $75.4 million (2024), whereas its average is $122.4 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first plummeted by 9535.67% in 2022, then surged by 72987.52% in 2023.
  • Quarter analysis of 5 years shows Supernus Pharmaceuticals' Change in Acquisitions & Divestments stood at $378.0 million in 2021, then tumbled by 95.36% to $17.6 million in 2022, then surged by 102.87% to $35.6 million in 2023, then soared by 273.5% to $133.0 million in 2024, then skyrocketed by 252.35% to $468.6 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $468.6 million for Q3 2025, versus $110.4 million for Q2 2025 and $156.2 million for Q1 2025.